.jpg)
US tariffs on pharmaceuticals risk shortages of lower-cost generic drugs
Vast majority of drugs prescribed in America are off-patent generics made in lower-cost countries
Vast majority of drugs prescribed in America are off-patent generics made in lower-cost countries
